A new research paper titled "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable ...
For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...
The US Centers for Medicare and Medicaid Services (CMS) is ending its requirement for coverage with evidence development for fluorodeoxyglucose positron emission tomography (FDG-PET) in oncology. In ...
FDG PET imaging measures glucose uptake in the brain. It has long served as a proxy for neuronal health—but is it? In the October 13 Science Translational Medicine, researchers led by Christian Haass ...
Prognostic significance of S100A4 expression in biliary tract cancers. Background: The role of F-18 FDG-PET/CT in gastric cancer is limited because of its low sensitivity. The sensitivity of F-18 ...
Multiple antigen stimulating cellular therapy (MASCT)-I for metastatic urothelial carcinoma (mUC): A multicenter, phase I study (MASCT-I-1001). This is an ASCO Meeting Abstract from the 2023 ASCO ...
An earlier indication of whether chemotherapy benefits non-small cell lung cancer patients -- provided by positron emission tomography (PET) imaging -- can guide doctors in offering them better care, ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results